Skip to main content

Table 1 The structures of the study group (including subdivisions) according to primary glomerulonephritis type, and the control group

From: Macrophage migration inhibitory factor urinary excretion revisited – MIF a potent predictor of the immunosuppressive treatment outcomes in patients with proliferative primary glomerulonephritis

 

Gender

Age (years) ± SD

Subgroup

Male

Female

Mean

Responders

Non-responders

Non-Proliferative GN

     

 MCD

3

7

36.0 ± 16.47

8

2

 FSGS

9

3

40.83 ± 13.17

7

5

 MN

5

6

45.81 ± 13.44

7

4

Proliferative GN

     

 MesGN

8

12

39.45 ± 15.34

13

7

 IgAN

10

10

39.80 ± 14.20

12

8

 MPGN

10

1

42.27 ± 11.88

6

5

 pooled

45

39

41.44 ± 13.25

53

31

Healthy

10

8

36.11 ± 13.29

-

-

Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us